Hospital Donación Francisco Santojanni

Recent papers from Hospital Donación Francisco Santojanni

1. Effects of sacubitril/valsartan versus enalapril on NT-proBNP and hs-troponin T in patients with heart failure due to Chagas disease: insights from the PARACHUTE-HF trialEuropean Heart Journal · 2026
2. Patient Risk Factors for Incidental Pathology After Uterovaginal Surgery for Apical Prolapse: Systematic Review and Global Expert Consensus StatementsInternational Urogynecology Journal · 2026
3. Monitoring of breathing effort through pressure time product measurement using airway occlusion pressure (PTPPOCC study)BMC Anesthesiology · 2026
4. Recurrence of ductal carcinoma in situ: A large South American multicenter analysis.Journal of Clinical Oncology · 2026
5. Clinical Characteristics and Outcomes of Bloodstream Infections Caused by Metallo-β-Lactamase–Producing Enterobacterales in Argentina: A Subanalysis of the EMBARCAR Prospective Multicenter Cohort StudyOpen Forum Infectious Diseases · 2026
6. Effects of Heat-Moisture Exchangers and Dead Space Compensation on CO ₂ Clearance and Mechanical Power in Critically Ill Intubated SubjectsRespiratory Care · 2026
7. Epidemiological Insights into Carbapenem-Resistant Enterobacterales Throughout the COVID-19 Pandemic in Buenos Aires, ArgentinaAntibiotics · 2026
8. Chemsex Practice Among PrEP Users in Buenos Aires, ArgentinaAIDS and Behavior · 2026
9. Pharmacological and rehabilitation strategies in opioid-induced constipation: an observational studyFrontiers in Rehabilitation Sciences · 2026
10. P-723. High Prevalence of Chemsex in PrEP Users in Buenos Aires, ArgentinaOpen Forum Infectious Diseases · 2026
11. P-268. Missed Opportunities and Factors Associated with Late Diagnosis of HIV Infection in the Era of Rapid TestingOpen Forum Infectious Diseases · 2026
12. A multicountry study to establish rates for pregnancy and neonatal outcomes in low- and middle-income regionsBMC Pregnancy and Childbirth · 2026
13. Negative Allosteric Modulation of Agonist-Induced M2 Muscarinic Receptor/β-Arrestin Interaction by Serum Autoantibodies from Patients with Chronic Chagas DiseaseCells · 2025
14. The Pharmacokinetic and Pharmacodynamic Drug-drug Interaction Potential of CannabidiolDrug Metabolism and Bioanalysis · 2025
15. A sustainable integrated agroforestry systemFrontiers in Plant Science · 2025
16. New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trialBMJ Open · 2025
17. Comparison of two Registries of Acute Coronary Syndrome in Argentina: STRATEG-SIA and SCAR (1999 – 2011)Revista Argentina de Cardiología · 2025
18. Development, Implementation, Pharmacokinetic and Safety Evaluation of an Immunotherapeutic Treatment for COVID-19: Double-blind Randomized Placebo-controlled TrialPrague Medical Report · 2025
19. Real‐World Experience of Dupilumab in Children and Adolescents With Atopic Dermatitis in ArgentinaPediatric Dermatology · 2025
20. Sacubitril/Valsartan Versus Enalapril in Chronic Chagas Cardiomyopathy with Heart Failure: Baseline Characteristics of the PARACHUTE-HF TrialEuropean Journal of Heart Failure · 2025